About Careers MedBlog Contact us

Johnson & Johnson Start Phase 1 Clinical Trial of Ebola Vaccine

by Dr. Trupti Shirole on January 7, 2015 at 12:53 PM
Font : A-A+

 Johnson & Johnson Start Phase 1 Clinical Trial of Ebola Vaccine

US pharmaceutical giant Johnson & Johnson has started human trials on a possible vaccine against Ebola. The company is hoping to move on to studies on large groups of patients by April.

The Oxford Vaccine Group at Britain's Oxford University is carrying out Phase I testing of the Ebola vaccine. 72 healthy volunteers are part of the test that will examine how their bodies tolerate the potential vaccine.


Johnson & Johnson said, "At the end of October we would spend up to $200 million to speed up and expand our Ebola vaccine program. We have already produced more than 400,000 doses, and two million courses will be ready by the year end. If necessary we can make five million doses within 12 to 18 months."

Source: Medindia


Recommended Reading

Latest Clinical Trials News

New Approach Uses Nanoparticles to Repair Lymphatic Vessels
Is there a new way to treat lymphedema? Yes, swelling due to damaged lymphatic vessels can be treated using nanoparticles that can travel through the lymphatic vessels.
 Chronic Traumatic Encephalopathy (CTE) Differs in Early and Late Stage
Early and late Chronic Traumatic Encephalopathy (CTE) disease processes in the post-mortem brains were similar in some ways but dramatically different in others.
 Preventing Scar Tissue After Heart Attack With Hydrogel Therapy
Researchers have developed a new hydrogel biomaterial that adheres to heart tissue to prevent scar tissue formation after a heart attack and its consequences.
 Cannabidiol (CBD) Oil for Urinary Stones Pain Relief: Do They Work
The oil extracted from Cannabidiol (CBD) present in cannabis (marijuana) does not lower pain scores after common treatment for urinary stones.
 New Temperature-Stable Tuberculosis (TB) Vaccine is Safe and Effective
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it prompted immune response and was safe.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Johnson & Johnson Start Phase 1 Clinical Trial of Ebola Vaccine Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests